share_log

Aimfinity Investment Corp. I Announces Seventh Extension of the Deadline for an Initial Business Combination to February 28, 2024

Aimfinity Investment Corp. I Announces Seventh Extension of the Deadline for an Initial Business Combination to February 28, 2024

Aimfinity Investment Corp. I 宣佈將初始業務合併的最後期限第七次延長至2024年2月28日
GlobeNewswire ·  01/26 17:00

Wilmington, Delaware, Jan.  26, 2024  (GLOBE NEWSWIRE) --  Aimfinity Investment Corp. I (the "Company" or "AIMA") (Nasdaq: AIMAU), a special purpose acquisition company incorporated as a Cayman Islands exempted company, today announced that, in order to extend the date by which the Company mush complete its initial business combination from January 28, 2024 to February 28, 2024, I-Fa Chang, sole member and manager of the sponsor of the Company, has deposited into its trust account (the "Trust Account") an aggregate of $85,000 (the "Monthly Extension Payment").

特拉華州威爾明頓,2024年1月26日(GLOBE NEWSWIRE)——作爲開曼群島豁免公司註冊的特殊目的收購公司Aimfinity Investment Corp. I(“公司” 或 “AIMA”)(納斯達克股票代碼:AIMAU)今天宣佈,爲了將公司完成初始業務合併的截止日期從2024年1月28日延長至2024年2月28日,唯一成員 I-Fa Chang 作爲公司保薦人的經理,已向其信託賬戶(“信託賬戶”)存入總額爲85,000美元(“每月延期付款”)。

Pursuant to the Company's second amended & restated memorandum and articles of association ("Current Charter"), effectively July 27, 2023, the Company may extend on a monthly basis from July 28, 2023 until April 28, 2024 or such an earlier date as may be determined by its board to complete a business combination by depositing the Monthly Extension Payment for each month into the Trust Account. This is the seventh of nine monthly extensions of the Company.  

根據公司第二份修訂和重述的備忘錄和章程(“現行章程”),自2023年7月27日起生效,公司可以按月將2023年7月28日延長至2024年4月28日或董事會可能確定的更早日期,通過將每月的每月延期付款存入信託賬戶來完成業務合併。這是公司九個月延期中的第七次。

About Aimfinity Investment Corp. I

關於 Aimfinity 投資公司 I

Aimfinity Investment Corp. I is a blank check company incorporated as a Cayman Islands exempted company for the purpose of effecting a merger, share exchange, asset acquisition, share purchase, reorganization or similar business combination with one or more businesses or entities. The Company has not selected any business combination target and has not, nor has anyone on its behalf, initiated any substantive discussions, directly or indirectly, with any business combination target with respect to an initial business combination with it. While the Company will not be limited to a particular industry or geographic region in its identification and acquisition of a target company, it will not complete its initial business combination with a target that is headquartered in China (including Hong Kong and Macau) or conducts a majority of its business in China (including Hong Kong and Macau).

Aimfinity Investment Corp. I是一家空白支票公司,註冊爲開曼群島豁免公司,其目的是與一個或多個企業或實體進行合併、股票交換、資產收購、股票購買、重組或類似的業務合併。公司沒有選擇任何業務合併目標,也沒有人代表公司直接或間接地與任何業務合併目標發起任何實質性討論,討論與其初始業務合併的目標。儘管公司在確定和收購目標公司時將不限於特定的行業或地理區域,但它不會完成與總部位於中國(包括香港和澳門)或在中國(包括香港和澳門)開展大部分業務的目標公司的初始業務合併。

Additional Information and Where to Find It

其他信息以及在哪裏可以找到

As previously disclosed, on October 13, 2023, the Company entered into that certain Agreement and Plan of Merger (as may be amended, supplemented or otherwise modified from time to time, the "Merger Agreement"), by and between the Company, Docter Inc., a Delaware corporation (the "Company"), Aimfinity Investment Merger Sub I, a Cayman Islands exempted company and wholly-owned subsidiary of Parent ("Purchaser"), and Aimfinity Investment Merger Sub II, Inc., a Delaware corporation and wholly-owned subsidiary of Purchaser ("Merger Sub"), pursuant to which the Company is proposing to enter into a business combination with Docter involving an reincorporation merger and an acquisition merger. This press release does not contain all the information that should be considered concerning the proposed business combination and is not intended to form the basis of any investment decision or any other decision in respect of the business combination. AIMA's stockholders and other interested persons are advised to read, when available, the proxy statement/prospectus and the amendments thereto and other documents filed in connection with the proposed business combination, as these materials will contain important information about AIMA, Purchaser or Docter, and the proposed business combination. When available, the proxy statement/prospectus and other relevant materials for the proposed business combination will be mailed to stockholders of AIMA as of a record date to be established for voting on the proposed business combination. Such stockholders will also be able to obtain copies of the proxy statement/prospectus and other documents filed with the Securities and Exchange Commission (the "SEC"), without charge, once available, at the SEC's website at www.sec.gov, or by directing a request to AIMA's principal office at 221 W 9th St, PMB 235 Wilmington, Delaware 19801.

正如先前披露的那樣,2023年10月13日,公司與特拉華州的一家公司Docter Inc.(“公司”)、開曼群島豁免公司兼母公司(“買方”)的全資子公司Aimfinity Investment Merger Sub I、開曼群島豁免公司和母公司(“買方”)的全資子公司Aimfinity Investment Merger Sub I 簽訂了該特定協議和合並計劃(可不時修改、補充或以其他方式修改 “合併協議”)特拉華州的一家公司兼買方(“Merger Sub”)的全資子公司ity Investment Merger Sub II, Inc.,根據該公司提議與Docter進行業務合併,涉及重組合並和收購合併。本新聞稿不包含有關擬議業務合併的所有應考慮的信息,也無意構成有關業務合併的任何投資決策或任何其他決定的基礎。建議AIMA的股東和其他利益相關人士(如果有)閱讀委託書/招股說明書及其修正案以及與擬議業務合併相關的其他文件,因爲這些材料將包含有關AIMA、Purcaser 或 Docter以及擬議業務合併的重要信息。擬議業務合併的委託書/招股說明書和其他相關材料將在創紀錄的日期郵寄給AIMA的股東,以便就擬議的業務合併進行投票。這些股東還可以在美國證券交易委員會(“SEC”)網站www.sec.gov上免費獲得向美國證券交易委員會(“SEC”)提交的委託書/招股說明書和其他文件的副本,或者直接向位於特拉華州威爾明頓市西九街221號PMB 235號的AIMA總部提出申請。

声明:本內容僅用作提供資訊及教育之目的,不構成對任何特定投資或投資策略的推薦或認可。 更多信息
    搶先評論